Cargando…
Methotrexate in Atherogenesis and Cholesterol Metabolism
Methotrexate is a disease-modifying antirheumatic drug commonly used to treat inflammatory conditions such as rheumatoid arthritis which itself is linked to increased cardiovascular risk. Treatments that target inflammation may also impact the cardiovascular system. While methotrexate improves cardi...
Autores principales: | Coomes, Eric, Chan, Edwin S. L., Reiss, Allison B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070167/ https://www.ncbi.nlm.nih.gov/pubmed/21490773 http://dx.doi.org/10.1155/2011/503028 |
Ejemplares similares
-
Cholesterol in the Cell Membrane—An Emerging Player in Atherogenesis
por: Paukner, Karel, et al.
Publicado: (2022) -
Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
por: Poznyak, Anastasia V., et al.
Publicado: (2022) -
Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis
por: Voloshyna, Iryna, et al.
Publicado: (2014) -
Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review
por: Goldberg, Doron, et al.
Publicado: (2022) -
Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis
por: Kotlyarov, Stanislav
Publicado: (2022)